Karen Aiach, Founder and CEO Lysogene, Neuilly-sur-Seine, FR, Cambridge MA, USA.
Gilles Avenard, MD Entrepreneur, CEO Acticor Biotech & Chairman of the Board, InnaVirVax Paris – France (FR).
Thomas Beck, MD Executive Partner, F-Prime Capital Partners, Cambridge MA, USA.
Youssef Bennani, PhD Vice-President R&D, Vertex Pharmaceuticals Inc., Head, Laval Site, Québec. [Vertex Pharmaceuticls Global HQ: Boston MA, USA]. BOD Chair, Domain Therapeutics, Strasbourg, FR.
Laure Berliner, Pharm D, MBA Chair, French American Biotech Spring Board (FABS) & Board Member, French American Chamber of Commerce of New England (FACCNE). Cambridge MA, USA.
Claude Bertrand, PhD PhD Chief Scientific Officer, Servier. Formerly, Executive Vice-President R&D, Chief Scientific Officer, IPSEN, Paris, FR
Professor Vincent Calvez Department Head, AP-HP Virology Laboratory, Pitié- Salpêtrière Hospital, & AC11 Group, ANRS: National French Agency for AIDS / Hepatitis, Paris, FR.
Pravin Chaturvedi, PhD Leader & Expert in Boston/Cambridge MA Biotechnology. CEO, PIVOT Pharmaceuticals; Co-Founder & CEO, Oceanyx Pharmaceuticals, BOD Member in 7 Biotechnology Companies, Woburn MA, USA.
Xavier Duportet, PhD CEO Eligo Bioscience, Paris; President, Hello-Tomorrow, Paris, FR, PhD MIT (Cambridge MA, USA) et INRIA (Paris, FR)
Vanessa Elharrar, MD* Fmr. Director of Therapeutic Research, Office of the Director, NIH: National Institutes of Health, Bethesda MD, USA  – *Designates immediate past affiliation
Dennis Gauvereau, PhD Director of International Affairs, Génopole, Evry, FR
Shahin Gharakhanian, MD, DPH Drug & Vaccine Clinical Development & Medical Affairs, USA/EU. CIC: Cambridge Innovation Center, Cambridge MA, USA – Founder: FABS: French American Biotech Spring Board. Cambridge MA, USA
Camilla Graham, MD, MPH, Vice President, Medical & Government Affairs, TREK Therapeutics, Assistant Professor of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School. Cambridge MA, USA
Maryvonne Hiance, Eng D President, FRANCE-BIOTECH: French Association of Biotechnology, Paris, FR.
Sofia Ioannidou, PhD Investment Director, Life Sciences. Edmond de Rothschild Investment Partners SAS, Paris, FR.
Pierre Legrain, PhD Vice-President for Development, Institut Pasteur, Paris, FR
Bernard Malfroy, PhD President and CEO at ViThera Laboratories, Arlington MA, USA – Program Committee Member, Annual Conference of the Massachusetts Biotechnology Council <Mass Bio>. Cambridge MA, USA.
James “Jim” Shanahan Co-Founder & Vice-President, Business Development, SynDevRx Inc, Cambridge MA – Founding Member, French-American Biotech Spring Board (FABS)
Don Sieffert Managing Editor, BOSTON BUSINESS JOURNAL. Boston MA, USA
Jacques-Bernard Taste President & Founder, BIOTECH-FINANCES, Lyon, France / Montréal, Québec, Canada
Emmanuelle Voisin, PhD CEO, VCLS: VOISIN Consulting Life Sciences, Paris (Boulogne-Billancourt), France – US Offices: Cambridge MA, Somerville NJ, San Francisco CA